Brinzolamide

FDA Approved: * November 27, 2020
Pharm Company: * WATSON LABS INC
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Brinzolamide Overview

Brinzolamide (trade names Azopt, Alcon Laboratories, Befardin,[2] Fardi Medicals,[3] ) is a carbonic anhydrase inhibitor used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Brinzolamide was approved as a generic medication in the United States in November 2020.[4] Contents 1 Chemistry 2 Indications 3 Pharmacodynamics 4 Pharmacokinetics 4.1 Absorption 4.2 Distribution 4.3 Metabolism 4.4 Excretion 5...

Read more Brinzolamide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Brinzolamide

Recent Brinzolamide Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Brinzolamide or a similar ingredient: (3 results)

• AZOPT Brinzolamide1 discussion
• BRINZOLAMIDE + BRIMONIDINE TARTRATE
• SIMBRINZA Brinzolamide + Brimonidine Tartrate2 discussions